Dehydroborapetoside B is primarily investigated for its potential bioactive properties, particularly in the field of natural product-based pharmaceutical research. It has shown promising antioxidant and anti-inflammatory activities in preliminary in vitro studies, making it a candidate for further exploration in therapeutic applications related to oxidative stress and chronic inflammation. Due to its structural complexity and glycosidic nature, it may also play a role in modulating cellular signaling pathways. Research is ongoing to evaluate its efficacy, bioavailability, and possible use in developing novel herbal or synthetic derivatives for medicinal purposes. Currently, it is not used in commercial products but remains of interest in academic and pharmacological studies focused on bioactive plant metabolites.